BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AHF: Gilead Sciences, Inc. (GILD)’s CEO Martin Joins “$50 Million Club”


8/1/2012 10:41:00 AM

LOS ANGELES--(BUSINESS WIRE)--On the heels of news that HIV/AIDS drug maker Gilead Sciences Inc.’s CEO John Martin has joined the “$50 million club” AIDS Healthcare Foundation (AHF), the nation’s largest HIV/AIDS nonprofit medical provider, criticized Martin and the company for providing him with such an ostentatious compensation package while the U.S. remains in the grips of an HIV/AIDS drug funding crisis. 1,800 Americans living with HIV/AIDS in nine states are currently on waiting lists to receive lifesaving medications through state AIDS Drug Assistance Programs (ADAPs), the safety net for low-income people in need of HIV/AIDS treatment. A key reason for the waiting lists is that high drug prices have made it so that fewer patients can be treated with the same amount of funding. Gilead manufactures the most commonly prescribed HIV/AIDS drugs, as well as some of the highest priced ones.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES